Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,999 | -2,821 | 2,931 | 6,817 | -3,837 |
| Depreciation Amortization | 98 | 94 | 63 | 19 | 69 |
| Income taxes - deferred | -382 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,978 | -1,522 | -1,157 | -620 | 789 |
| Other Working Capital | -3,033 | -514 | -1,293 | -1,106 | 1,145 |
| Other Operating Activity | -5,782 | -7,792 | -8,770 | -8,477 | 264 |
| Operating Cash Flow | $-18,074 | $-12,554 | $-8,226 | $-3,367 | $-1,570 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 275 | N/A | N/A | N/A | N/A |
| Net Acquisitions | 29,107 | 29,107 | 29,107 | 29,107 | N/A |
| Investing Cash Flow | $29,382 | $29,107 | $29,107 | $29,107 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -16 |
| Common Stock Issued | 750 | 750 | N/A | 750 | 1,513 |
| Other Financing Activity | 0 | 0 | 750 | 0 | 0 |
| Financing Cash Flow | $750 | $750 | $750 | $750 | $1,497 |
| Beginning Cash Position | 104 | 104 | 104 | 104 | 176 |
| End Cash Position | 12,162 | 17,407 | 21,734 | 26,593 | 104 |
| Net Cash Flow | $12,058 | $17,303 | $21,631 | $26,489 | $-72 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,074 | -12,554 | -8,226 | -3,367 | -1,570 |
| Free Cash Flow | -18,074 | -12,554 | -8,226 | -3,367 | -1,570 |